HOUSTON--(BUSINESS WIRE)--DNAtrix was awarded $10.8 Million Grant by the Cancer Prevention and Research Institute of Texas. The grant will be used for the clinical development of DNX-2401 for treating glioblastoma.
Reported by Business Wire 28 minutes ago.
HOUSTON--(BUSINESS WIRE)--DNAtrix was awarded $10.8 Million Grant by the Cancer Prevention and Research Institute of Texas. The grant will be used for the clinical development of DNX-2401 for treating glioblastoma.
Reported by Business Wire 28 minutes ago.